Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon

NCT00209313 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

HIV-1 and HSV-2 Coinfection
HIV Infections

Interventions

DRUG: Acyclovir

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]